Cargando…

Cellular localization of the proto-oncogenic p53 inhibitor AGR2 protein in breast cancer

Detalles Bibliográficos
Autores principales:	Fourtouna, A, Hupp, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300717/ http://dx.doi.org/10.1186/bcr1898

Ejemplares similares

Characterization of peptide aptamers to the Anterior Gradient 2: a novel inhibitor of the tumour suppressor protein p53
por: Fourtouna, A, et al.
Publicado: (2006)

Discrepancy between jun/fos proto-oncogene mRNA and protein expression in the rheumatoid arthritis synovial membrane
por: Huber, R, et al.
Publicado: (2005)

Disorders of the cMyb proto-oncogene expression and its significance in the course of ATL development
por: Nakano, Kazumi, et al.
Publicado: (2014)

AGR2, a novel metastasis inducing protein with an effect on breast cancer patient survival
por: Barraclough, DL, et al.
Publicado: (2006)

Kaposi sarcoma associated herpesvirus infection of primary human endothelial cells activates the proto-oncogene STAT3
por: King, Christine A, et al.
Publicado: (2012)

Secretion of pro-oncogenic AGR2 protein in cancer
por: Moidu, Nurshahirah Ashikin, et al.
Publicado: (2020)

The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation
por: Harrod, Robert, et al.
Publicado: (2015)

Cooperation between the human T-cell leukemia virus type-1 p30(II) protein and host cellular factors during oncogenic transformation and retroviral carcinogenesis
por: Romeo, Megan, et al.
Publicado: (2014)

D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest
por: Aoubala, M, et al.
Publicado: (2010)

The Sequence-specific Peptide-binding Activity of the Protein Sulfide Isomerase AGR2 Directs Its Stable Binding to the Oncogenic Receptor EpCAM
por: Mohtar, M. Aiman, et al.
Publicado: (2018)

D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity
por: Aoubala, M
Publicado: (2008)

Role of proto-oncogene activation in carcinogenesis.
por: Anderson, M W, et al.
Publicado: (1992)

The Biology of the Ets1 Proto-Oncogene
por: Dittmer, Jürgen
Publicado: (2003)

Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells
por: Brown, Geoffrey
Publicado: (2021)

p53β isoform modulates differentially p53 transcriptional activity in response to stress
por: Fernandes, K, et al.
Publicado: (2008)

0356. Effect of the neuroprotective p53-inhibitor pifithrin-µ in a rodent cardiac arrest model
por: Springe, D, et al.
Publicado: (2014)

Inhibitor of apoptosis proteins in breast cancer
por: Foster, FM, et al.
Publicado: (2006)

Abnormal expression of p53 isoforms can be associated with poor survival in primary breast tumours
por: Bourdon, J-C
Publicado: (2008)

Expression of ret Proto‐oncogene in Human Neuroblastomas
por: Nagao, Minako, et al.
Publicado: (1990)

Roles of the RET Proto-oncogene in Cancer and Development
por: Takahashi, Masahide, et al.
Publicado: (2020)

PBF, a Proto-oncogene in Esophageal Carcinoma
por: Lian, Shi-hai, et al.
Publicado: (2019)

Abrogation of Brd4 cellular function contributes to the oncogenic mechanisms of translocation t(15;19)-associated carcinoma
por: Wang, Ranran, et al.
Publicado: (2013)

Structural effect of P278A mutation conferring breast cancer susceptibility in the p53 DNA-binding core domain
por: Suneetha, Y, et al.
Publicado: (2012)

Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis
por: Ding, Donglin, et al.
Publicado: (2023)

Genetic, metabolic and cellular factors influencing intracellular localization of the Wilson disease protein, ATP7B
por: Gupta, Arnab, et al.
Publicado: (2014)

The in vivo function of the p53 target gene TIGAR
por: Cheung, Eric C, et al.
Publicado: (2012)

Differential cellular localization of antioxidant enzymes in the trigeminal ganglion
por: Shibata, M, et al.
Publicado: (2013)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
por: Kyndi, M, et al.
Publicado: (2005)

Activation of proto-oncogenes in human and mouse lung tumors.
por: Reynolds, S H, et al.
Publicado: (1991)

Analyses of domains and domain fusions in human proto-oncogenes
por: Liu, Qi, et al.
Publicado: (2009)

The Proto-Oncogene TWIST1 Is Regulated by MicroRNAs
por: Nairismägi, Maarja-Liisa, et al.
Publicado: (2013)

The impact of the MYB-NFIB fusion proto-oncogene in vivo
por: Mikse, Oliver R., et al.
Publicado: (2016)

Distribution of RET proto‐oncogene variants in children with appendicitis
por: Schultz, Jurek, et al.
Publicado: (2022)

Laser nanostructured gold biosensor for proto-oncogene detection
por: Hughes, Cian, et al.
Publicado: (2023)

P29. T-cell responses to oncogenic Merkel cell polyomavirus proteins distinguish Merkel cell carcinoma patients from healthy donors
por: Lyngaa, L, et al.
Publicado: (2014)

Inhibitor of apoptosis proteins as a therapeutic target in breast cancer
por: Foster, FM, et al.
Publicado: (2008)

Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)

p53, a novel regulator of lipid metabolism pathways
por: Goldstein, Ido, et al.
Publicado: (2012)

P53 - Smoking during pregnancy and asthma’s manifestation in childhood
por: Maggina, Paraskevi, et al.
Publicado: (2014)

Proto-oncogene Src links lipogenesis via lipin-1 to breast cancer malignancy
por: Song, Lintao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4jqab87csuh67mc3tnpl0n3glj